Literature DB >> 24267604

Clostridium difficile infection in the elderly.

Jonathan M Keller1, Christina M Surawicz.   

Abstract

Clostridium difficile-associated illness is an increasingly prevalent and morbid condition. The elderly population is at a disproportionate risk of developing symptomatic disease and associated complications, including progression to severe or fulminant disease, and development of recurrent infections. This article analyzes the factors that influence C difficile disease propensity and severity, with particular attention directed toward features relevant to the rapidly aging population.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic-associated diarrhea; Clostridium difficile; Elderly

Mesh:

Substances:

Year:  2014        PMID: 24267604     DOI: 10.1016/j.cger.2013.10.008

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  32 in total

1.  Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.

Authors:  Yuying Luo; Emily N Tixier; Ari M Grinspan
Journal:  Dig Dis Sci       Date:  2020-02-20       Impact factor: 3.199

2.  Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.

Authors:  Krishna Rao; Dejan Micic; Mukil Natarajan; Spencer Winters; Mark J Kiel; Seth T Walk; Kavitha Santhosh; Jill A Mogle; Andrzej T Galecki; William LeBar; Peter D R Higgins; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2015-03-31       Impact factor: 9.079

Review 3.  The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

Review 4.  Nutrition and the gut microbiome in the elderly.

Authors:  Nuria Salazar; Lorena Valdés-Varela; Sonia González; Miguel Gueimonde; Clara G de Los Reyes-Gavilán
Journal:  Gut Microbes       Date:  2016-11-03

5.  Editorial commentary: Host-pathogen interactions in Clostridium difficile infection: it takes two to tango.

Authors:  David M Aronoff
Journal:  Clin Infect Dis       Date:  2014-03-05       Impact factor: 9.079

6.  The microbiota and microbiome in aging: potential implications in health and age-related diseases.

Authors:  Heidi J Zapata; Vincent J Quagliarello
Journal:  J Am Geriatr Soc       Date:  2015-04-08       Impact factor: 5.562

Review 7.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 8.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

9.  Treatment of bacterial skin infections in ED observation units: factors influencing prescribing practice.

Authors:  John P Haran; Gregory Wu; Vanni Bucci; Andrew Fischer; Edward W Boyer; Patricia L Hibberd
Journal:  Am J Emerg Med       Date:  2015-08-21       Impact factor: 2.469

Review 10.  Clostridium difficile and the microbiota.

Authors:  Anna M Seekatz; Vincent B Young
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.